Gerresheimer, a provider of drug delivery systems and other products to the pharma industry, has reported revenues of EUR 285.1m for the third quarter of the 2011 financial year, a rise of 9.9% from the same period last year.
Subscribe to our email newsletter
The company has posted a net income of EUR19.2m for the quarter, indicating a rise by 36% ascompared to the corresponding period of the previous year.
Adjusted earnings per share rose by 35% to EUR 0.70
Gerresheimer has posted adjusted EBITDA of EUR 57.1m in the third quarter of 2011, as compared to EUR53.3m in the prior year.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.